Most of the take overs of emerging Biotech companies with Promising Products, take Place after successful completion of phase II Trials (as it was also insinuated by our MD in the latest PAB announcement), NOT Completion of phase III....
Major Pharma companies are Very well Conversant with the Nature and Potential of Phase II Trials of most small Biotechs (especially those ala PAB, with exceptionally exciting prospects), and make decisions accordingly....
So, it will not be long now, before we (hopefully) hear SOME EXTREMELY GOOD News, from several fronts.....
Cheers:)))
Great new week to all;)))
on track.., page-24
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $7.201M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $564 | 161.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 29348732 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 26555626 | 17 |
View Market Depth
| Last trade - 12.59pm 18/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |